Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout

NCT01650246 is registered in ClinicalTrials.gov with Ardea Biosciences, Inc. as lead sponsor.

NCT NCT01650246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01650246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Lead sponsor
Ardea Biosciences, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
August 31, 2014
Enrollment
143 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

gout